
    
      Participants of the HPV V503-004 study (Phase III Clinical trial vaccinating (young) adult
      women in Antwerp, EudraCT NUMBER: 2015-005093-38) will be asked if they are willing to
      provide two additional urine samples at day 1 and month 7 for biomedical research. The
      collected urine will be used for the development and optimisation of robust analytical
      protocols for sample preparation and antibody assays.
    
  